Document is current
Any future updates will be listed below
-
Authors
Owens, Max M. https://orcid.org/0000-0002-5560-4077
Albaugh, Matthew D.
Allgaier, Nicholas https://orcid.org/0000-0002-9498-0200
Yuan, Dekang
Robert, Gabriel
Cupertino, Renata B.
Spechler, Philip A. https://orcid.org/0000-0003-3833-7672
Juliano, Anthony https://orcid.org/0000-0001-7433-6891
Hahn, Sage
Banaschewski, Tobias https://orcid.org/0000-0003-4595-1144
Bokde, Arun L. W. https://orcid.org/0000-0003-0114-4914
Desrivières, Sylvane https://orcid.org/0000-0002-9120-7060
Flor, Herta
Grigis, Antoine
Gowland, Penny https://orcid.org/0000-0002-4900-4817
Heinz, Andreas https://orcid.org/0000-0001-5405-9065
Brühl, Rüdiger https://orcid.org/0000-0003-0111-5996
Martinot, Jean-Luc https://orcid.org/0000-0002-0136-0388
Martinot, Marie-Laure Paillère
Artiges, Eric https://orcid.org/0000-0003-4461-7646
Nees, Frauke https://orcid.org/0000-0002-7796-8234
Orfanos, Dimitri Papadopoulos https://orcid.org/0000-0002-1242-8990
Lemaitre, Herve
Paus, Tomáš https://orcid.org/0000-0003-1495-9338
Poustka, Luise
Millenet, Sabina
Fröhner, Juliane H. https://orcid.org/0000-0002-8493-6396
Smolka, Michael N. https://orcid.org/0000-0001-5398-5569
Walter, Henrik https://orcid.org/0000-0002-9403-6121
Whelan, Robert https://orcid.org/0000-0002-2790-7281
Mackey, Scott
Schumann, Gunter https://orcid.org/0000-0002-7740-6469
Garavan, Hugh
,
Banaschewski, Tobias
Barker, Gareth J.
Bokde, Arun L. W.
Desrivières, Sylvane
Flor, Herta
Grigis, Antoine
Garavan, Hugh
Gowland, Penny
Heinz, Andreas
Brühl, Rüdiger
Martinot, Jean-Luc
Martinot, Marie-Laure Paillère
Artiges, Eric
Nees, Frauke
Orfanos, Dimitri Papadopoulos
Lemaitre, Herve
Paus, Tomáš
Poustka, Luise
Hohmann, Sarah
Millenet, Sabina
Fröhner, Juliane H.
Smolka, Michael N.
Walter, Henrik
Whelan, Robert
Schumann, Gunter
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (K08 MH121654-01A1)
- License Information
-
More Information
Article History
Received: 3 December 2021
Revised: 18 April 2022
Accepted: 22 April 2022
First Online: 6 May 2022
Competing interests
: This work was funded by NIH/NIDA T32DA043593 and R01DA047119. MDA is supported by K08 MH121654 and a NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation. This work received support from the following sources: the European Union-funded FP6 Integrated Project IMAGEN (Reinforcement-related behavior in normal brain function and psychopathology) (LSHM-CT- 2007-037286), the Horizon 2020 funded ERC Advanced Grant “STRATIFY” (Brain network based stratification of reinforcement-related disorders) (695313), Human Brain Project (HBP SGA 2, 785907, and HBP SGA 3, 945539), the Medical Research Council Grant “c-VEDA” (Consortium on Vulnerability to Externalizing Disorders and Addictions) (MR/N000390/1), the National Institute of Health (NIH) (R01DA049238, A decentralized macro and micro gene-by-environment interaction analysis of substance use behavior and its brain biomarkers), the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London, the Bundesministeriumfür Bildung und Forschung (BMBF grants 01GS08152; 01EV0711; Forschungsnetz AERIAL 01EE1406A, 01EE1406B; Forschungsnetz IMAC-Mind 01GL1745B), the Deutsche Forschungsgemeinschaft (DFG grants SM 80/7-2, SFB 940, TRR 265, NE 1383/14-1), the Medical Research Foundation and Medical Research Council (grants MR/R00465X/1 and MR/S020306/1), the National Institutes of Health (NIH) funded ENIGMA (grants 5U54EB020403-05 and 1R56AG058854-01), NSFC grant 82150710554 and environMENTAL grant. Further support was provided by grants from: - the ANR (ANR-12-SAMA-0004, AAPG2019 - GeBra), the Eranet Neuron (AF12-NEUR0008-01 - WM2NA; and ANR-18-NEUR00002-01 - ADORe), the Fondation de France (00081242), the Fondation pour la Recherche Médicale (DPA20140629802), the Mission Interministérielle de Lutte-contre-les-Drogues-et-les-Conduites-Addictives (MILDECA), the Assistance-Publique-Hôpitaux-de-Paris and INSERM (interface grant), Paris Sud University IDEX 2012, the Fondation de l’Avenir (grant AP-RM-17-013), the Fédération pour la Recherche sur le Cerveau; the National Institutes of Health, Science Foundation Ireland (16/ERCD/3797), U.S.A. (Axon, Testosterone and Mental Health during Adolescence; RO1 MH085772-01A1) and by NIH Consortium grant U54 EB020403, supported by a cross-NIH alliance that funds Big Data to Knowledge Centres of Excellence. TB served in an advisory or consultancy role for Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, Shire. He received conference support or speaker’s fee by Lilly, Medice, Novartis, and Shire. He has been involved in clinical trials conducted by Shire & Viforpharma. He received royalties from Hogrefe, Kohlhammer, CIP Medien, Oxford University Press. The present work is unrelated to the above grants and relationships. Dr. Barker has received honoraria from General Electric Healthcare for teaching on scanner programming courses. LP served in an advisory or consultancy role for Roche and Viforpharm and received speaker’s fee by Shire. She received royalties from Hogrefe, Kohlhammer, and Schattauer. The present work is unrelated to the above grants and relationships. The other authors report no biomedical financial interests or potential conflicts of interest.
